États-Unis d'Amérique

Émirats arabes unis

Renseignements non divulgués

Please indicate how many grants of marketing approval for unauthorized copies of patented pharmaceutical products have been reversed in the last five years. Please address any ongoing efforts to reverse marketing approvals for unauthorized copies of patented pharmaceutical products and to prevent any further registrations of such products.

On March 27, the UAE engage very fruitful consultations with the US officials with the aim of exploring ways and means of enhancing protection of patented pharmaceutical. Following these consultations, the UAE made written commitments to provide comprehensive protection for US pharmaceuticals including extending data exclusivity protection. These commitments, which confirm the UAE obligations under the TRIPS Agreement, will be implemented on an MFN basis as stipulated by the Agreement.